Yanggang Feng and colleagues designed a lightweight (0.96 kg) wearable knee robot to assist isokinetic training for children with SMA type II, an intermediate form of the condition. In a clinical trial, they tested outcomes in six children (aged 6–10 years old) who could not stand from a seated position without assistance.
Sentante announced today that it received CE mark for its flagship endovascular surgical robot platform for treating stroke.
Galvanize Therapeutics announced today that it received FDA clearance for its Aliya EX generator for the surgical ablation of soft tissue.
Microsure announced today that it received CE mark approval for its MUSA-3 surgical robot and named Alex Joseph as CEO.
A Concordia-led team of researchers has developed a new AI-driven robotic system that can perform cardiac ultrasound scans autonomously. The researchers say this approach could expand access to cardiac imaging in remote or underserved areas, reduce operator fatigue, and standardize scan quality. The work is published in the journal IEEE Transactions on Medical Robotics and Bionics.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Stealth AXiS surgical robot platform.
Restore Robotics announced new FDA 510(k) clearances for the remanufacturing of two Intuitive da Vinci Xi robotic surgical instruments.
Researchers at King’s College London have shown for the first time that AI can autonomously perform thrombectomy navigation in a physical lab setting, a step toward expanding access to life-saving stroke treatment. For their study, now published in IEEE Robotics and Automation Letters, the team developed a robotic system that uses AI to navigate the complex pathway through blood vessels from the leg to the brain during mechanical thrombectomy (MT).
HENDERSON, Nev., March 31, 2026 /PRNewswire/ — Restore Robotics today announced it has received additional 510(k) clearances from the U.S. Food and Drug Administration (FDA) for the remanufacturing of two more da Vinci Xi® robotic surgical instruments. This milestone expands Restore Robotics’ growing portfolio of cleared instruments and further strengthens its position as a leader in robotic instrument remanufacturing.
Procept BioRobotics (Nasdaq:PRCT) today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.